209 related articles for article (PubMed ID: 32987917)
1. Abscisic Acid Treatment in Patients with Prediabetes.
Derosa G; Maffioli P; D'Angelo A; Preti PS; Tenore G; Novellino E
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32987917
[TBL] [Abstract][Full Text] [Related]
2. Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.
Grant SJ; Chang DH; Liu J; Wong V; Kiat H; Bensoussan A
BMC Complement Altern Med; 2013 May; 13():104. PubMed ID: 23672597
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of the thickness of preperitoneal and subcutaneous fat layer in the abdomen estimated by ultrasonography for diagnosing abdominal obesity in each type of impaired glucose tolerance in man.
Soyama A; Nishikawa T; Ishizuka T; Ito H; Saito J; Yagi K; Saito Y
Endocr J; 2005 Apr; 52(2):229-36. PubMed ID: 15863953
[TBL] [Abstract][Full Text] [Related]
4. Effects of n-3 pufas on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance.
Derosa G; Cicero AF; D'Angelo A; Borghi C; Maffioli P
Biofactors; 2016 May; 42(3):316-22. PubMed ID: 27040503
[TBL] [Abstract][Full Text] [Related]
5. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.
Derosa G; Cicero AF; Fogari E; D'Angelo A; Bonaventura A; Romano D; Maffioli P
J Clin Lipidol; 2012; 6(6):553-64. PubMed ID: 23312051
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effect of soybean (Glycine max (L.) Merr.) leaf extracts in adults with prediabetes: a randomized placebo controlled trial.
Choi MS; Ryu R; Seo YR; Jeong TS; Shin DH; Park YB; Kim SR; Jung UJ
Food Funct; 2014 Jul; 5(7):1621-30. PubMed ID: 24873894
[TBL] [Abstract][Full Text] [Related]
7. Decreased insulin secretion and insulin sensitivity are associated with liver function in subjects with fasting glucose between 100 and 109 mg/dL in Taiwanese population.
Hsiao JY; Wang CL; Hsia PJ; Hsieh MC; Hsin SC; Lin KD; Shin SJ
Pancreas; 2007 Nov; 35(4):343-7. PubMed ID: 18090240
[TBL] [Abstract][Full Text] [Related]
8. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Hansis-Diarte A; Jenkinson C; Tripathy D; Folli F
Acta Diabetol; 2018 Feb; 55(2):139-148. PubMed ID: 29151224
[TBL] [Abstract][Full Text] [Related]
9. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of carotid intima media thickness in impaired fasting glucose and impaired glucose tolerance.
Aydin Y; Berker D; Ustün I; Gül K; Erden G; Kutlucan A; Yilmaz Aydin L; Güler S
Minerva Endocrinol; 2011 Sep; 36(3):171-9. PubMed ID: 22019748
[TBL] [Abstract][Full Text] [Related]
11. Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes.
Malin SK; Haus JM; Solomon TP; Blaszczak A; Kashyap SR; Kirwan JP
Am J Physiol Endocrinol Metab; 2013 Nov; 305(10):E1292-8. PubMed ID: 24064339
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism.
Karbek B; Cakal E; Cakir E; Bozkurt N; Unsal I; Sahin M; Delibaşi T
Minerva Endocrinol; 2013 Sep; 38(3):297-304. PubMed ID: 24126550
[TBL] [Abstract][Full Text] [Related]
13. Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial.
Moreira-Lucas TS; Duncan AM; Rabasa-Lhoret R; Vieth R; Gibbs AL; Badawi A; Wolever TM
Diabetes Obes Metab; 2017 Jan; 19(1):133-141. PubMed ID: 27717236
[TBL] [Abstract][Full Text] [Related]
14. Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT: An IMI DIRECT Study.
Tura A; Grespan E; Göbl CS; Koivula RW; Franks PW; Pearson ER; Walker M; Forgie IM; Giordano GN; Pavo I; Ruetten H; Dermitzakis ET; McCarthy MI; Pedersen O; Schwenk JM; Adamski J; De Masi F; Tsirigos KD; Brunak S; Viñuela A; Mahajan A; McDonald TJ; Kokkola T; Vangipurapu J; Cederberg H; Laakso M; Rutters F; Elders PJM; Koopman ADM; Beulens JW; Ridderstråle M; Hansen TH; Allin KH; Hansen T; Vestergaard H; Mari A;
Diabetes; 2021 Sep; 70(9):2092-2106. PubMed ID: 34233929
[TBL] [Abstract][Full Text] [Related]
15. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
Chakarova N; Tankova T; Atanassova I; Dakovska L
Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
[TBL] [Abstract][Full Text] [Related]
16. Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.
Moors CC; van der Zijl NJ; Diamant M; Blaak EE; Goossens GH
Int J Obes (Lond); 2012 May; 36(5):709-17. PubMed ID: 21712806
[TBL] [Abstract][Full Text] [Related]
17. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.
Abdul-Ghani MA; Jenkinson CP; Richardson DK; Tripathy D; DeFronzo RA
Diabetes; 2006 May; 55(5):1430-5. PubMed ID: 16644701
[TBL] [Abstract][Full Text] [Related]
18. Fasting Glucose State Determines Metabolic Response to Supplementation with Insoluble Cereal Fibre: A Secondary Analysis of the Optimal Fibre Trial (OptiFiT).
Kabisch S; Meyer NMT; Honsek C; Gerbracht C; Dambeck U; Kemper M; Osterhoff MA; Birkenfeld AL; Arafat AM; Hjorth MF; Weickert MO; Pfeiffer AFH
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590438
[TBL] [Abstract][Full Text] [Related]
19. Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?
Perreault L; Bergman BC; Playdon MC; Dalla Man C; Cobelli C; Eckel RH
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E428-35. PubMed ID: 18523123
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism.
Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Tripathy D; Jenkinson C; Folli F
Diabetes Care; 2015 Aug; 38(8):1509-17. PubMed ID: 26084344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
